Residual Risk From Remnant Cholesterol and Inflammation Despite Lipid-Lowering Therapy and Associ...
October 25, 2026
Share
Residual Risk From Remnant Cholesterol and Inflammation Despite Lipid-Lowering Therapy and Association With Incident Peripheral Artery Disease in Type 2 Diabetes.